CABOTIB 60MG TAB

CABOTIB 60MG TAB is a prescription medication used to treat certain types of cancer, including:

• Hepatocellular carcinoma (HCC) in patients with advanced disease who have not responded to previous therapy
• Intrahepatic cholangiocarcinoma (iCC) in patients with advanced disease who have not responded to previous therapy
• Non-small cell lung cancer (NSCLC) in patients with advanced disease who have not responded to previous therapy

It is a tyrosine kinase inhibitor that works by blocking the action of the c-MET protein, which is involved in the development and growth of cancer cells.

Composition:

Each tablet of CABOTIB 60MG TAB contains 60mg of cobozantinib.

Mechanism of Action:

Cobozantinib works by:

• Blocking the action of the c-MET protein, which is involved in the development and growth of cancer cells
• Inhibiting the formation of new blood vessels that feed the tumor
• Reducing the growth and proliferation of cancer cells

Uses:

CABOTIB 60MG TAB is used to treat certain types of cancer, including:

• Hepatocellular carcinoma (HCC) in patients with advanced disease who have not responded to previous therapy
• Intrahepatic cholangiocarcinoma (iCC) in patients with advanced disease who have not responded to previous therapy
• Non-small cell lung cancer (NSCLC) in patients with advanced disease who have not responded to previous therapy

Dosage:

The recommended dosage of CABOTIB 60MG TAB is:

• 60mg taken orally once daily, with or without food

Side Effects:

Common side effects of CABOTIB 60MG TAB include:

• Diarrhea
• Fatigue
• Nausea and vomiting
• Abdominal pain
• Rash
• Constipation
• Decreased appetite

Recommendation:

CABOTIB 60MG TAB is recommended for patients who have not responded to previous therapy for their specific type of cancer. Patients should also be advised to monitor their liver function and thyroid function regularly during treatment.

Important Note:

Patients should not take CABOTIB 60MG TAB if they have a history of severe allergic reactions, bleeding disorders, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as liver or kidney problems, before taking CABOTIB 60MG TAB.

Some common brands of cobozantinib include:

• Cabometyx (Exelixis)
• Cabozantinib (Exelixis)

Please note that CABOTIB 60MG TAB is not available in all markets and may be approved for different indications and dosages in different regions.